KZR Kezar Life Sciences Kelajakdagi narxning foydaga nisbati

kezarlifesciences.com - KZR emitenti grafik logotipi

Kezar Life Sciences (KZR) autoimmunitega qarshi kurashishning kichik molekulalar segmentida raqobatlashmoqda, bu yerda muvaffaqiyat FDA qarorlariga bog'liq. GURU.Markets platformasida kompaniyaning oldingi P/E ko'rsatkichi o'zgarishi bozor kutganlarini ko'rsatadi, 0.00 esa ushbu parametr darajasini belgilaydi. Biznes noyob immunoproteasoma protein terapiyasi tizimini yaratmoqda, hozirda esa kapitalni optimallashtirmoqda va eng istiqbolli klinik sinovlarga e'tibor qaratmoqda.

Prognoz qilingan narxning foydaga nisbati: Kezar Life Sciences Inc. (KZR) 04.07.2022 - 23.05.2026 uchun

Kezar Life Sciences (KZR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

Kompaniyaning barcha koʻrsatkichlari tahlili:KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc brend mahsuloti

Ushbu ko'rsatkichning dinamikasi operatsion xarajatlar va prognoz qilingan sof foyda o'rtasidagi muvozanatga bog'liq bo'lib, aksiyaning bozor qiymatini kutilayotgan kelajakdagi daromadlar nisbatida o'lchaydi. Onkologiya markazlari bilan ittifoqlar orqali immunofarmatsevtika sohasida sinergiya yaratuvchi Kezar Life Sciences (KZR) uchun kompaniyaning forward P/E qiymati ishlab chiqilayotgan proteasoma inhibitorlarining tijorat muvaffaqiyatiga bozor ishonchining ko'rsatkichi bo'lib xizmat qiladi.

Raqobatdosh kompaniyalar tahlili

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - Forvard P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori AKTX|Kelajakdagi narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Kelajakdagi narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Prognoz qilingan narxning foydaga nisbati|EDSA - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iBio|CARM: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Kelajakdagi narxning foydaga nisbati boltbio.com|Forvard P/E multiplikatori HCW Biologics|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori